Henshaw Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-9,920
Closed -$384K 258
2022
Q3
$384K Buy
9,920
+1,115
+13% +$44.7K 0.03% 170
2022
Q2
$328K Hold
8,805
0.02% 201
2022
Q1
$390K Hold
8,805
0.02% 199
2021
Q4
$374K Hold
8,805
0.02% 215
2021
Q3
$382K Hold
8,805
0.02% 204
2021
Q2
$377K Hold
8,805
0.02% 223
2021
Q1
$340K Sell
8,805
-10,643
-55% -$403K 0.02% 240
2020
Q4
$699K Buy
19,448
+382
+2% +$13.8K 0.05% 126
2020
Q3
$729K Sell
19,066
-880
-4% -$33.9K 0.06% 121
2020
Q2
$700K Buy
19,946
+2,208
+12% +$79.5K 0.06% 116
2020
Q1
$579K Buy
17,738
+8,258
+87% +$323K 0.06% 116
2019
Q4
$429K Buy
9,480
+883
+10% +$36.9K 0.03% 157
2019
Q3
$350K Hold
8,597
0.03% 184
2019
Q2
$369K Buy
8,597
+710
+9% +$27.3K 0.03% 175
2019
Q1
$303K Sell
7,887
-537
-6% -$20.5K 0.03% 203
2018
Q4
$298K Hold
8,424
0.03% 188
2018
Q3
$324K Sell
8,424
-219
-3% -$7.65K 0.03% 211
2018
Q2
$283K Hold
8,643
0.03% 247
2018
Q1
$236K Buy
+8,643
New +$235K 0.02% 272

Other funds holding BSX

Henshaw Capital's BSX Position: Q4 2022 in Review

Henshaw Capital sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 9,920 shares — an estimated $384K sold.

Henshaw Capital first reported a position in BSX in Q1 2018 and held it in 19 quarters. The position peaked at $729K in Q3 2020. 930 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Henshaw Capital reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
  • Henshaw Capital sold 9,920 Boston Scientific shares in Q4 2022, an estimated $384K.
  • Henshaw Capital first reported a position in Boston Scientific in Q1 2018 and held it in 19 quarters.
  • Henshaw Capital's Boston Scientific position peaked at $729K in Q3 2020.
  • 930 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Henshaw Capital's 13F filing for Q4 2022, filed 28 May 2026.